Recent Thymic Emigrants of the CD4 T-cell Lineage
Recent Thymic Emigrants of the CD4 T-cell Lineage
批准号:
8074705
负责人:
DAVID BRAM LEWIS
金额:
$16.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-06 至 2011-06-30
关键词:
AccountingAdultAllogenicB-LymphocytesBiological AssayBlood CirculationCD4 Positive T LymphocytesCD8B1 geneCell CountCell LineageCell physiologyCellsChildClinicalCytotoxic agentDNADNA Sequence RearrangementDiseaseEmigrantEvaluationExcisionFamilyFlow CytometryFrequenciesGene ExpressionGene Expression ProfilingGenerationsGenesGrowthHIV-1Half-LifeHealthHematopoietic Stem Cell TransplantationHematopoietic stem cellsHighly Active Antiretroviral TherapyHumanImmuneImmune responseImmune systemImmunityImmunologic Deficiency SyndromesImpairmentIn VitroIndividualInfantInfectionInterventionJointsKineticsKnowledgeLabelLymphopeniaMature ThymocyteMessenger RNAMolecular ProfilingMonitorMyasthenia GravisNeonatalOutputPatientsPeripheralPharmaceutical PreparationsPhenotypePlayPopulationProductionProtein Tyrosine KinaseProteinsReceptor Protein-Tyrosine KinasesReceptor-CD3 Complex, Antigen, T-CellRecoveryResearchResidual stateRoleSignal TransductionSiteStem cell transplantSurfaceT-Cell ReceptorT-LymphocyteTestingThymectomyThymus GlandTransplantationVaccinesbaseimmune functionimmunosenescencein vivointerestmRNA Expressionmembermemory CD4 T lymphocytenovelnovel markerperipheral bloodpublic health relevancereconstitutionthymocyteyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Antigenically naive CD4 expressing a¿-T cell receptors are critical for generating immune responses to neoantigens, and are produced de novo within the thymus as mature CD4+CD8- thymocytes. These enter the periphery to become recent thymic emigrants (RTEs) of the naive CD4 T-cell compartment. Although monitoring of CD4 RTEs is of great clinical interest, particularly in CD4 T-cell lymphopenia, direct evaluation of human CD4 RTEs has been limited by a lack of specific surface markers. This project will utilize a novel and recently identified surface marker for human CD4 RTEs, protein tyrosine kinase 7 (PTK7), to define CD4 RTE frequency, phenotype, and function. Preliminary results validate PTK7 as a CD4 RTE marker, and show that PTK7+ CD4 RTEs have a reduced capacity for effector function compared to PTK7- naive CD4 T cells. Aim 1 will use gene expression profiling by deep mRNA sequencing of unstimulated and stimulated PTK7+ CD4 RTEs and other CD4 T-lineage cells to: 1) define the extent of residual thymocyte gene expression in PTK7+ CD4 RTEs during ontogeny, and 2) identify gene products involved in reduced CD4 RTE immune function, particularly for Th1 generation and/or that subdivide PTK7+ CD4 RTEs into more versus less recent thymic emigrants. Aim 2 will use in vivo labeling to test the hypothesis that PTK7+ CD4 RTEs are the direct precursors of PTK7- naive CD4 T cells, and will determine the role of PTK7+ CD4 RTEs in maintaining naive CD4 T-cell numbers and 12-TCR repertoire diversity in HIV-1 infection. Aim 3 will use a similar approach to test the importance of PTK7+ CD4 RTEs in immune reconstitution of naive CD4 T cells after allogeneic hematopoietic stem cell transplantation. Aim 4 will define the kinetics of loss of PTK7+ CD4 RTEs in children and adults following complete thymectomy and the impact of this loss on naive CD4 T-cell numbers and 12- TCR repertoire diversity. Together, these studies will substantially enhance our understanding of the role of thymic RTE production in maintaining the peripheral naive CD4 T-cell compartment in health and disease.
PUBLIC HEALTH RELEVANCE: The production of new CD4 T cells by the thymus, which are also known as CD4 recent thymic emigrants (RTEs), is important for the immune system to respond to infections and vaccines. This research will evaluate the production and function of CD4 RTEs, in healthy individuals and in patients with diseases or treatments that may alter RTE production; this knowledge will also help identify patients that might benefit by treatment with drugs to increase RTE production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transitional and Naive CD4 T cells and B cells in Infant Vaccine Responses
-
批准号:8452046
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2012
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Transitional and Naive CD4 T cells and B cells in Infant Vaccine Responses
-
批准号:8645611
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2012
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Transitional and Naive CD4 T cells and B cells in Infant Vaccine Responses
-
批准号:8299284
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2012
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Transitional and Naive CD4 T cells and B cells in Infant Vaccine Responses
-
批准号:9032985
-
项目类别:
-
资助金额:$35.09万
-
财政年份:2012
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Recent Thymic Emigrants of the CD4 T-cell Lineage
-
批准号:8606146
-
项目类别:
-
资助金额:$40.37万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
-
批准号:8144428
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Recent Thymic Emigrants of the CD4 T-cell Lineage
-
批准号:8425085
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Recent Thymic Emigrants of the CD4 T-cell Lineage
-
批准号:8212566
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
-
批准号:8319660
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Recent Thymic Emigrants of the CD4 T-cell Lineage
-
批准号:8020944
-
项目类别:
-
资助金额:$43.32万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Recent Thymic Emigrants of the CD4 T-cell Lineage
-
批准号:7897586
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
-
批准号:8088907
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2010
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Recent Thymic Emigrants of the CD4 T-cell Lineage
-
批准号:7859607
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2009
-
负责人:DAVID BRAM LEWIS
-
依托单位:
CD4 T cell Immunity to Influenza
-
批准号:7657179
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2008
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Educational Component
-
批准号:7657163
-
项目类别:
-
资助金额:$10.16万
-
财政年份:2008
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Training Program in Adult and Pediatric Rheumatology
-
批准号:10205655
-
项目类别:
-
资助金额:$31.08万
-
财政年份:2005
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Training Program in Adult and Pediatric Rheumatology
-
批准号:10427292
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2005
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Training Program in Adult and Pediatric Rheumatology
-
批准号:10672358
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2005
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Postnatal ontogeny of HCMV-specific CD4 T cell immunity
-
批准号:6600409
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2002
-
负责人:DAVID BRAM LEWIS
-
依托单位:
Postnatal ontogeny of HCMV-specific CD4 T cell immunity
-
批准号:6454157
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2001
-
负责人:DAVID BRAM LEWIS
-
依托单位:
海外基金